Bactheravax is developing a new class of microbiome-targeted immunotherapies designed to address tumor-resident bacteria that contribute to immune suppression, therapy resistance, and poor clinical outcome in cancer.
| Website | https://bactheravax.com/ |
| Employees | 3 (2 on RocketReach) |
| Industry | Biotechnology Research |
Looking for a particular Bactheravax employee's phone or email?
Bactheravax Questions
Ivo Ploemen is the CEO and Co-Founder of Bactheravax.
2 people are employed at Bactheravax.
Top Bactheravax Employees
-
Dinja Oosterhoff
CSO and Co-Founder at Bactheravax
Amsterdam, NH, NL2
G2Crowd Trusted
300K+
Plugin Users
